1-2 IPSGs
1-2 IPSGs
1-2 IPSGs
Patient
Safety
Goals
Dr. Fathi Mohamed Ali
TQM-AUC
By Studying this Lecture, you
will be able to:
Know the 6
International Patient
Safety Goals
Improving Patient Safety
means . . .
Displayed at all
imaging consoles
Have you checked the
Patient ID ?
- Prior to the Procedure -
sure !
ESR Preparation tools
8. Scope of risk (Patient Identification) Checklist
LEGEND: PT = Preparation Tool INT = Interview OBS = Observation MR = Medical Record O/I = Observation/Interview
DR=Document Review
NM =Not met (Score 0 less than 49%) PM = Partially met (Score 2 If 50% to 79%) FM = Fully met( Score 3 If 80% or more) NA =
Not applicable(Cancelled Score )
RESULT COMMENTS
Points of measurement PT FM PM NM NA
Each Patient has a unique identifier number registered by
DR+OBS
medical records
Patients are identified by 2 identifiers which are the unique
medical records number and the patient's full name (at least DR+O/I
triple name)
At least the two patient identifiers are used before collecting
DR+O/I
blood samples and other specimens for clinical testing.
At least the two patient identifiers are used before
DR+O/I
administering blood, or blood components.
At least the two patient identifiers are used when
DR+O/I
administering medications.
At least the two patient identifiers are used before providing
DR+O/I
treatments or procedures.
Two nurses or one nurse and a physician verify the patient’s
DR+O/I
identity prior to blood drawing for cross match.
Two nurses or one nurse and a physician verify the patient’s
DR+O/I
identity prior to blood drawing for cross match.
Two nurses or one nurse and a physician verify the patient’s
DR+O/I
identity prior to blood drawing for cross match.
Communication
Improve Effective Communication
• B = When I walked Mrs. Elmer to the bathroom for her bath she
had SOB than she didn’t have on Monday (today is
Wednesday). Mrs. Elmer also verbalized that she weighs 2 lbs
more than yesterday. I also noticed that her ankles are swollen.
If I press on the swollen area and remove my finger you can
see the indentation.
• Potassium Chloride
• Potassium Phosphate
• Sodium Chloride > 0.9%
High-alert medications (cont.)
)األدوية عالية الخطورة (تابع
High-alert medication
Insulin
High-alert medications (cont.)
)األدوية عالية الخطورة (تابع
High-alert medication
Insulin
High-alert medications (cont.)
)األدوية عالية الخطورة (تابع
High-alert medication
Antithrombotic agents
(anticoagulants)
High-alert medications (cont.)
)األدوية عالية الخطورة (تابع
High-alert medication
Potassium chloride
ESR Preparation tools
MM.5 The hospital has a system for the safety of high-alert medications.
MM.5.1 - There is a written multidisciplinary plan for managing high-alert medications and
hazardous pharmaceutical chemicals. It includes identification, location, labeling, storage,
dispensing, and administration of high-alert medications.
Activity: Document Review
Review the multidisciplinary plan for managing high-alert medications and hazardous
pharmaceutical chemicals.
Required Documents...
There is a written multidisciplinary plan for managing high-alert
High-alert Medications and
medications and hazardous pharmaceutical chemicals. It
Hazardous Chemicals
includes identification, location, labeling, storage, dispensing,
Multidisciplinary Plan
and administration of high-alert medications.
ESR Preparation tools
MM.5.2 - The hospital identifies an annually updated list of high-alert medications and
hazardous pharmaceutical chemicals based on its own data and national and international
recognized organizations (e.g., Institute of Safe Medication Practice, World Health
Organization). The list contains, but is not limited to, the following:
MM.5.2.1 Controlled and narcotics medications.
MM.5.2.2 Neuromuscular blockers.
MM.5.2.3 Chemotherapeutic agents.
MM.5.2.4 Concentrated electrolytes (e.g., hypertonic sodium chloride, concentrated potassium salts).
MM.5.2.5 Antithrombotic medications (e.g., heparin, warfarin).
MM.5.2.6 Insulins.
MM.5.2.7 Anesthetic medications (e.g., propofol, ketamine).
MM.5.2.8 Investigational (research) drugs, as applicable.
MM.5.2.9 Other medications as identified by the hospital.
Activity: Document Review
Review the updated list of high-alert medications and hazardous pharmaceutical chemicals
(MM.5.2.1 - MM.5.2.9).
Required Documents...
The hospital identifies an annually updated list of high-alert medications
and hazardous pharmaceutical chemicals based on its own data and
national and international recognized organizations (e.g., Institute of
Safe Medication Practice, World Health Organization). The list contains,
High-Alert but is not limited to, the following: MM.5.2.1 Controlled and narcotics
Medications and medications. MM.5.2.2 Neuromuscular blockers. MM.5.2.3
Hazardous Chemotherapeutic agents. MM.5.2.4 Concentrated electrolytes (e.g.,
Chemicals List hypertonic sodium chloride, concentrated potassium salts). MM.5.2.5
Antithrombotic medications (e.g., heparin, warfarin). MM.5.2.6 Insulins.
MM.5.2.7 Anesthetic medications (e.g., propofol, ketamine). MM.5.2.8
Investigational (research) drugs, as applicable. MM.5.2.9 Other
medications as identified by the hospital.
ESR Preparation tools
MM.5.3 - The hospital plan for managing high-alert medications and hazardous pharmaceutical
chemicals is implemented. This includes, but is not limited to, the following:
MM.5.3.1 Improving access to information about high-alert medications.
MM.5.3.2 Limiting access to high-alert medications.
MM.5.3.3 Using auxiliary labels or computerized alerts if available.
MM.5.3.4 Standardizing the ordering, transcribing, preparation, dispensing, administration, and
monitoring of high-alert medications.
MM.5.3.5 Employing independent double checks.
Activity: Observation
Observe for evidence of implementation of high alert plan (MM.5.3.1 - MM.5.3.5).
Staff interview to look for evidence of implementation of high alert plan (MM.5.3.1 - MM.5.3.5).
ESR Preparation tools
MM.5.4 - The hospital develops and implements standard concentrations for all medications
administered by intravenous infusion.
Activity: Document Evidence
Review the hospital approved standard concentration for all medications administered by
intravenous infusion.
Required Documents...
Evidence of Implementation of The hospital develops and implements standard
Standard Concentrations of IV concentrations for all medications administered by
Infusions intravenous infusion.
ESR Preparation tools
MM.6 The hospital has a system for the safety of look-alike and sound-alike (LASA)
medications.
MM.6.1 - There is a multidisciplinary policy and procedure on handling look- alike/sound-alike
(LASA) medications.
Activity: Document Review
MM.6.2 - The hospital reviews and revises annually its list of confusing drug names, which
include LASA medication name pairs that the hospital stores, dispenses, and administers.
Activity: Document Review
Review the updated list of confusing drug names including LASA medications.
ESR Preparation tools
MM.6.3 - The hospital takes actions to prevent errors involving LASA medications
including the following, as applicable:
MM.6.3.1 Providing education on LASA medications to healthcare professionals at orientation and
as part
of continuing education.
MM.6.3.2 Using both the brand and generic names for prescribing LASA
medications. MM.6.3.3 Writing the diagnosis/ indication of the LASA
medication on the prescription. MM.6.3.4 Changing the appearance of look-
alike product package.
MM.6.3.5 Reading carefully the label each time a medication is accessed, and/or prior to
administration.
MM.6.3.6 Minimizing the use of verbal and telephone orders.
MM.6.3.7 Checking the purpose/indication of the medication on the prescription prior to
dispensing and administering.
MM.6.3.8 Placing LASA medications in locations separate from each other or in non-alphabetical
order.
Activity: Observation
Observe for evidence of error prevention due to LASA medications (from MM.6.3.2 to MM.6.3.8)
Staff interview for evidence of error prevention due to LASA medications (from MM.6.3.1 to
MM.6.3.8)
39. Scope of risk (High Alert Medication-
Concentrated Electrolytes) Checklist
LEGEND: PT = Preparation Tool INT = Interview OBS = Observation MR = Medical Record O/I =
Observation/Interview DR=Document Review NM =Not met (Score 0 less than 49%) PM = Partially met (Score 2 If
50% to 79%) FM = Fully met( Score 3 If 80% or more) NA = Not applicable(Cancelled Score)
RESULT COMMENTS
Points of measurement
PT FM PM NM NA
Availability of Written policy for the inventory, handling, DR
storage, dispensing and administration of high alert
medications (including the definition of high alert medication
and a defined global list and unit lists)
Only privileged physicians may order intravenous medications DR+
(Midazolam, ketamine) in doses intended to provide
anesthesia.
High alert medications are present in patient care units OBS
according to approved list and in minimal quantities.
High alert medications are secured when stored in patient care OBS
units
High alert medications dispensing is double checked and DR
documented +OBS
RESULT COMMENTS
Points of measurement PT
FM PM NM NA
QM.18.6 - The hospital documents its processes for preventing wrong patient, wrong
site, and wrong surgery/procedure.
Activity: Open Medical Record Review
Review the medical record of a patient went for any invasive procedure to make sure that the pre-
procedure verification, site marking, and time out are noted in the chart.
18. Scope of risk (Verification Process/Time
Out) Checklist
LEGEND: PT = Preparation Tool INT = Interview OBS = Observation MR = Medical Record O/I = Observation/Interview
DR=Document Review
NM =Not met (Score 0 less than 49%) PM = Partially met (Score 2 If 50% to 79%) FM = Fully met( Score 3 If 80% or more) NA = Not
applicable(Cancelled Score )
RESULT COMMENTS
Points of measurement PT
FM PM NM NA
Time- Out is done before skin incision and after starting anesthesia, and is OBS
read out loud
Time- Out is done with nurse, anesthetist and surgeon or his/ her designee OBS
The surgeon or his/ her designee, anesthetist and nurse verbally confirm the OBS
patient’s name.
The surgeon, anesthetist and nurse verbally confirm the procedure. OBS
The surgeon provides information regarding the critical or non-routine OBS
steps, if any.
The surgeon provides information regarding how long will the case take. OBS
The surgeon provides information regarding how much blood loss is OBS
anticipated
The anesthetist provides information regarding any patient-specific OBS
concerns.
The nurse has confirmed the sterility of the instrumentation (including OBS
indicator results).
The nurse has confirmed whether there are equipment issues or concerns. OBS
N95
Airborne Precautions